Korean J Clin Microbiol.  1999 Mar;2(1):64-70.

Antimicrobial Resistance and Serotypes in the Clinical Isolates of Group B Streptococci

  • 1Department of Clinical Pathology, Yonsei University Wonju College of Medicine, Wonju, Korea. u931018@yonsei.wonju.ac. kr


BACKGROUND: This study is designed to provide data on the trend of resistance by year of isolation in the clinical isolates of group B streptococci(GBS) during recent eight years and to elucidate the relationship between serotypes and antimicrobial resistance patterns.
The minimal inhibitory concentrations (MIC) of seven antimicrobial agents and serotypes for 150 strains of GBS isolated from clinical specimens between 1990 and 1997 were investigated.
The resistance rate of 150 clinical isolates of GBS were 20.0% to clindamycin, 16.0% to erythromycin, 4.0% to chloramphenicol, and 95.3% to tetracycline. None was resistant to penicillin, ceftriaxone, or vancomycin. Of the 24 isolates resistant to erythromycin, 20 (83.3%) were resistant to clindamycin. Resistance rates of erythromycin according to serotypes in decreasing order were 69.2% (V), 23.2% (III), and 3.5% (Ib). All serotypes Ia and II were susceptible to erythromycin and clindamycin.
Striking emergence of resistant strains to erythromycin and clindamycin in our clinical isolates of GBS was mainly due to sudden increase of serotype V and III which shows multi-drug resistance phenotype.


Group B streptococci (GBS); Antimicrobial susceptibility; Erythromycin resistance; Clindamycin resistance; Serotype
Full Text Links
  • KJCM
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr